Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2719 results

Sort By:

A Phase Ib Study of the Selective PKC-β Inhibitor MS-553 in Patients With Refractory or Relapsed CLL/SLL

Study ID: NCT06979076
Start Date: 2026-07
End Date: 2028-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

12

Intervention / Treatment

MS-553, DS1

MS-553, DS2

Sponsor

MingSight Pharmaceuticals, Inc

Source: clinicaltrials.gov

Share:
Add to list

Substance Use in Assault-Injured Young Adults

Study ID: NCT07070414
Start Date: 2026-08
End Date: 2028-02
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

Brief Negotiation Interview intervention (BNI) (adapted)

Sponsor

Yale University

Source: clinicaltrials.gov

Share:
Add to list

Microneedling Alone Versus Microneedling Coupled With Either Bleomycin or 5flourouracil in the Treatment of Plantar Warts

Study ID: NCT07041749
Start Date: 2026-06-01
End Date: 2027-07-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

Bleomycin

Microneedling alone

5 fluorouracil

Sponsor

Assiut University

Source: clinicaltrials.gov

Share:
Add to list

Sex-Based Differences of LA: Impact on AF Ablation.

Study ID: NCT07159685
Start Date: 2026-01-01
End Date: 2026-05-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

700

Intervention / Treatment

Atrial fibrillation ablation

Sponsor

Teknon Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Adapting Changing Talk: Online (CHATO) to CHATO-Inclusive

Study ID: NCT06636214
Start Date: 2026-08-31
End Date: 2029-08-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

1200

Intervention / Treatment

BORING-I

Sponsor

University of Kansas Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Olanzapine for Managing Anorexia in Head and Neck Cancer Patients Undergoing Chemoradiation, MACRO Trial

Study ID: NCT06995508
Start Date: 2025-11-15
End Date: 2031-11-15
Study Type

Interventional

Study Phase

Phase2

No. of Participants

66

Intervention / Treatment

Best Practice

Olanzapine

Administration Questionnaire

Sponsor

Roswell Park Cancer Institute

Source: clinicaltrials.gov

Share:
Add to list

Transition From Acute to Chronic Opioid Use and Chronic Pain

Study ID: NCT07211399
Start Date: 2026-01-01
End Date: 2030-12-01
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

700

Intervention / Treatment

Opioid-free anesthesia

Opioid-based anesthesia

Sponsor

Jacques E. Chelly

Source: clinicaltrials.gov

Share:
Add to list

Mitigating Burnout in Nursing and Associated Healthcare Staff

Study ID: NCT07018609
Start Date: 2026-04-01
End Date: 2028-04-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

300

Intervention / Treatment

Zen Den Experience

Music Therapy Experience

Sponsor

Milton S. Hershey Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Open, Randomized Feasibility Trial on the Safety and Performance of the INGA Catheter for Labor Induction

Study ID: NCT07214948
Start Date: 2026-01-05
End Date: 2026-10-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

90

Intervention / Treatment

NO Catheters

Currently used single balloon catheter

Sponsor

Aalto University

Source: clinicaltrials.gov

Share:
Add to list

dApagliflozin SC0062 and Prevention of Renal Injury; a Randomized Evaluation

Study ID: NCT06072326
Start Date: 2026-01
End Date: 2028-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

36

Intervention / Treatment

Dapagliflozin (Forxiga®)

SC0062 strength 10mg

SC0062 and dapagliflozin

Sponsor

University Medical Center Groningen

Source: clinicaltrials.gov

Share:
Add to list